SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012931
Filing Date
2022-05-12
Accepted
2022-05-12 08:29:28
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 519218
2 ex31-1.htm EX-31.1 19343
3 ex31-2.htm EX-31.2 19327
4 ex32-1.htm EX-32.1 8003
5 ex32-2.htm EX-32.2 8165
  Complete submission text file 0001493152-22-012931.txt   2922905

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE indp-20220331.xsd EX-101.SCH 26190
7 XBRL CALCULATION FILE indp-20220331_cal.xml EX-101.CAL 40532
8 XBRL DEFINITION FILE indp-20220331_def.xml EX-101.DEF 72948
9 XBRL LABEL FILE indp-20220331_lab.xml EX-101.LAB 243875
10 XBRL PRESENTATION FILE indp-20220331_pre.xml EX-101.PRE 176591
46 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 334681
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 22915830
SIC: 2834 Pharmaceutical Preparations